A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

Status:
Completed

Trial end date:
2017-08-10

Target enrollment:

Participant gender:

The purpose of this study is to understand if multiple oral doses of BMS-986166 are safe and well tolerated in healthy patients.

Phase 1

Bristol-Myers Squibb